Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain. The сompany is engaged in developing products for hospitals and ambulatory care settings that are developing non-opioid products for the treatment of serious acute pain. The сompany's lead product candidate is an injectable form of meloxicam.